Literature DB >> 28101189

Inhibition of cytoskeletal protein carbonylation may protect against oxidative damage in traumatic brain injury.

Qiusheng Zhang1, Meng Zhang2, Xianjian Huang2, Xiaojia Liu2, Weiping Li2.   

Abstract

Oxidative stress is the principal factor in traumatic brain injury (TBI) that initiates protracted neuronal dysfunction and remodeling. Cytoskeletal proteins are known to be carbonylated under oxidative stress; however, the complex molecular and cellular mechanisms of cytoskeletal protein carbonylation remain poorly understood. In the present study, the expression levels of glutathione (GSH) and thiobarbituric acid reactive substances (TBARS) were investigated in PC12 cells treated with H2O2. Western blot analysis was used to monitor the carbonylation levels of β-actin and β-tubulin. The results indicated that oxidative stress was increased in PC12 cells that were treated with H2O2 for 24 or 48 h. In addition, increased carbonylation levels of β-actin and β-tubulin were detected in H2O2-treated cells. However, these carbonylation levels were reduced by pretreatment with aminoguanidine, a type of reactive carbonyl species chelating agent, and a similar trend was observed following overexpression of proteasome β5 via transgenic technology. In conclusion, the present study results suggested that the development of TBI may cause carbonylation of cytoskeletal proteins, which would then undermine the stability of cytoskeletal proteins. Thus, the development of TBI may be improved via the inhibition of cytoskeletal protein carbonylation.

Entities:  

Keywords:  aminoguanidine; oxidative stress; proteasome; protein carbonylation; traumatic brain injury

Year:  2016        PMID: 28101189      PMCID: PMC5228077          DOI: 10.3892/etm.2016.3889

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  24 in total

Review 1.  Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.

Authors:  David J Loane; Alan I Faden
Journal:  Trends Pharmacol Sci       Date:  2010-10-29       Impact factor: 14.819

2.  Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates.

Authors:  Niki Chondrogianni; Christos Tzavelas; Alexander J Pemberton; Ioannis P Nezis; A Jennifer Rivett; Efstathios S Gonos
Journal:  J Biol Chem       Date:  2005-01-20       Impact factor: 5.157

3.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

4.  Proteomic identification of nitrated brain proteins in traumatic brain-injured rats treated postinjury with gamma-glutamylcysteine ethyl ester: insights into the role of elevation of glutathione as a potential therapeutic strategy for traumatic brain injury.

Authors:  Tanea T Reed; Joshua Owen; William M Pierce; Andrea Sebastian; Patrick G Sullivan; D Allan Butterfield
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

5.  The epidemiology and impact of traumatic brain injury: a brief overview.

Authors:  Jean A Langlois; Wesley Rutland-Brown; Marlena M Wald
Journal:  J Head Trauma Rehabil       Date:  2006 Sep-Oct       Impact factor: 2.710

6.  PKC-beta1 mediates EGF protection of microtubules and barrier of intestinal monolayers against oxidants.

Authors:  A Banan; J Z Fields; D A Talmage; Y Zhang; A Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

7.  Potentiation of diclofenac-induced anti-inflammatory response by aminoguanidine in carrageenan-induced acute inflammation in rats: the role of nitric oxide.

Authors:  A A Al-Majed; M Khattab; M Raza; O A Al-Shabanah; A M Mostafa
Journal:  Inflamm Res       Date:  2003-09       Impact factor: 4.575

8.  Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage.

Authors:  F Zhang; C Iadecola
Journal:  Brain Res       Date:  1998-08-17       Impact factor: 3.252

Review 9.  Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

10.  Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomyelitis.

Authors:  Suzanne M Smerjac; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2007-12-10       Impact factor: 5.372

View more
  1 in total

Review 1.  β-Actin: An Emerging Biomarker in Ischemic Stroke.

Authors:  Jiaqian Li; Fangyu Dai; Xuelian Kou; Bin Wu; Jie Xu; Songbin He
Journal:  Cell Mol Neurobiol       Date:  2022-05-13       Impact factor: 5.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.